安徽医药
安徽醫藥
안휘의약
ANHUI MEDICAL AND PHARMACEUTICAL JOURNAL
2015年
5期
1008-1009,1010
,共3页
张云玲%贺思勋%朱学应%方丽梅
張雲玲%賀思勛%硃學應%方麗梅
장운령%하사훈%주학응%방려매
中/长链脂肪乳注射液%专项点评%合理用药
中/長鏈脂肪乳註射液%專項點評%閤理用藥
중/장련지방유주사액%전항점평%합리용약
MCT/LCT emulsion injection%special comment%rational use of drug
目的:评价该院中/长链脂肪乳注射液临床使用合理性,为其合理用药提供参考。方法抽取2013年8—12月份该院所有使用中/长链脂肪乳注射液的住院患者的病历,采集相关信息,根据相关标准进行专项点评。结果调查的331例患者中,外科所占比例最大,57.70%;其次为结核科17.82%、呼吸科10.57%、肿瘤科9.67%、急诊科3.63%、内科0.60%。不合理病例比例为34.44%。无适应证用药17.52%,遴选药品不适宜5.74%,用法用量不正确0.00,有配伍禁忌的为3.63%,未监测脂肪廓清能力13.60%。结论从调查结果中发现,中/长链脂肪乳注射液临床应用不合理现象较为普遍,医院需进一步强化药物规范使用。
目的:評價該院中/長鏈脂肪乳註射液臨床使用閤理性,為其閤理用藥提供參攷。方法抽取2013年8—12月份該院所有使用中/長鏈脂肪乳註射液的住院患者的病歷,採集相關信息,根據相關標準進行專項點評。結果調查的331例患者中,外科所佔比例最大,57.70%;其次為結覈科17.82%、呼吸科10.57%、腫瘤科9.67%、急診科3.63%、內科0.60%。不閤理病例比例為34.44%。無適應證用藥17.52%,遴選藥品不適宜5.74%,用法用量不正確0.00,有配伍禁忌的為3.63%,未鑑測脂肪廓清能力13.60%。結論從調查結果中髮現,中/長鏈脂肪乳註射液臨床應用不閤理現象較為普遍,醫院需進一步彊化藥物規範使用。
목적:평개해원중/장련지방유주사액림상사용합이성,위기합리용약제공삼고。방법추취2013년8—12월빈해원소유사용중/장련지방유주사액적주원환자적병력,채집상관신식,근거상관표준진행전항점평。결과조사적331례환자중,외과소점비례최대,57.70%;기차위결핵과17.82%、호흡과10.57%、종류과9.67%、급진과3.63%、내과0.60%。불합리병례비례위34.44%。무괄응증용약17.52%,린선약품불괄의5.74%,용법용량불정학0.00,유배오금기적위3.63%,미감측지방곽청능력13.60%。결론종조사결과중발현,중/장련지방유주사액림상응용불합리현상교위보편,의원수진일보강화약물규범사용。
Objective To evaluate the rational clinical use of MCT/LCT emulsion injection to provide reference for its rational use. Methods Collected relevant information by extracting medical records of all the inpatient who injected with MCT/LCT emulsion from Aug,2013 to Dec,2013,and gave special comments in accordance with the relevant standards.Results Among the 311 cases,patients from the surgery department hold the largest proportion (57.70%),followed by the tuberculosis department,accounting for 17.82%. The rest are respiratory department which holds 10.57%,oncology department holding 9.67%,emergency department holding 3.63%, and internal medicine holding 0.60%.Unreasonable medical records take 34.44%;no indication of medication use takes 17.52%,in-appropriate selection of drugs takes 5.74%,incorrect dosage takes 0.00,incompatibility takes 3.63%,and unmonitored fat clearance capacity takes 13.60%.Conclusions Based on the survey results,unreasonable use of MCT/LCT emulsion injection in clinical appli-cation is more prevalent,and hospital needs to further strengthen the standardized drug use.